Fulgent Genetics Net Income 2015-2025 | FLGT

Fulgent Genetics net income from 2015 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Fulgent Genetics Annual Net Income
(Millions of US $)
2024 $-43
2023 $-168
2022 $143
2021 $507
2020 $214
2019 $0
2018 $-6
2017 $-3
2016 $-5
2015 $-8
2014 $-4
Fulgent Genetics Quarterly Net Income
(Millions of US $)
2025-03-31 $-12
2024-12-31 $-6
2024-09-30 $-15
2024-06-30 $-9
2024-03-31 $-13
2023-12-31 $-128
2023-09-30 $-13
2023-06-30 $-11
2023-03-31 $-15
2022-12-31 $-24
2022-09-30 $2
2022-06-30 $12
2022-03-31 $154
2021-12-31 $104
2021-09-30 $123
2021-06-30 $80
2021-03-31 $201
2020-12-31 $166
2020-09-30 $47
2020-06-30 $3
2020-03-31 $-2
2019-12-31 $0
2019-09-30 $1
2019-06-30 $0
2019-03-31 $-2
2018-12-31 $-2
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-1
2017-06-30 $0
2017-03-31 $0
2016-12-31 $1
2016-09-30 $-1
2016-06-30 $-5
2016-03-31 $-1
2015-12-31
2015-09-30 $0
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.594B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.022B 58.55
Tempus AI (TEM) United States $11.820B 0.00
Doximity (DOCS) United States $11.014B 50.99
Hims & Hers Health (HIMS) United States $9.614B 99.88
IRhythm Technologies (IRTC) United States $4.905B 0.00
Inspire Medical Systems (INSP) United States $3.910B 61.09
Hinge Health (HNGE) United States $3.661B 0.00
Privia Health (PRVA) United States $2.683B 183.42
Enovis (ENOV) United States $1.826B 10.18
Phreesia (PHR) United States $1.658B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
Clover Health Investments (CLOV) United States $1.445B 0.00
Azenta (AZTA) United States $1.378B 64.06
Omnicell (OMCL) United States $1.363B 24.05
10x Genomics (TXG) United States $1.341B 0.00
Evolent Health (EVH) United States $1.247B 106.20
Claritev (CTEV) United States $0.667B 0.00
Butterfly Network (BFLY) United States $0.497B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.480B 143.50
Standard BioTools (LAB) United States $0.463B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.346B 768.33
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.210B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
American Well (AMWL) United States $0.114B 0.00
CareCloud (CCLD) United States $0.109B 4.15
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
111 (YI) China $0.067B 0.00
HeartBeam (BEAT) United States $0.050B 0.00
P3 Health Partners (PIII) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00